A detailed history of Truvestments Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Truvestments Capital LLC holds 2,234 shares of VTRS stock, worth $28,193. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,234
Holding current value
$28,193
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $23,054 - $27,098
2,234 New
2,234 $25,000
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $18,110 - $21,742
-1,607 Reduced 53.42%
1,401 $16,000
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $12,637 - $15,634
1,441 Added 91.96%
3,008 $32,000
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $9 - $11
1 Added 0.06%
1,567 $15,000
Q2 2023

Aug 10, 2023

BUY
$9.02 - $10.29 $9 - $10
1 Added 0.06%
1,566 $15,000
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $5,538 - $7,380
-602 Reduced 27.78%
1,565 $15,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $8,789 - $11,652
-1,008 Reduced 31.75%
2,167 $24,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $1,500 - $1,970
177 Added 5.9%
3,175 $27,000
Q2 2022

Aug 09, 2022

BUY
$9.95 - $12.27 $29,830 - $36,785
2,998 New
2,998 $31,000
Q1 2022

May 02, 2022

SELL
$9.81 - $15.4 $16,618 - $26,087
-1,694 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $1,172 - $1,423
-97 Reduced 5.42%
1,694 $23,000
Q3 2021

Oct 29, 2021

BUY
$13.25 - $15.13 $26 - $30
2 Added 0.11%
1,791 $24,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $25,187 - $31,363
-1,942 Reduced 52.05%
1,789 $26,000
Q1 2021

May 18, 2021

BUY
$13.59 - $18.54 $18,183 - $24,806
1,338 Added 55.91%
3,731 $53,000
Q4 2020

Feb 17, 2021

BUY
$14.3 - $18.74 $34,219 - $44,844
2,393 New
2,393 $44,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.